Newsroom: Confluent Announces Significant Investment in ATI Nitinol Melt Expansion

Confluent Medical Technologies Acquires Corpus Medical, Combining Advanced Catheter Technology Design and Development with Confluent Medical Manufacturing Capabilities

FREMONT, Calif.–(BUSINESS WIRE)–Confluent Medical Technologies (“Confluent Medical”), a global leader in medical device contract manufacturing, today completed the acquisition of Corpus Medical. Confluent Medical is a contract manufacturer with full scale capabilities to provide high-quality, low cost finished class III medical devices. Confluent’s core capabilities revolve around industry-leading expertise in balloon catheters, delivery systems, introducer sheaths, Nitinol products, and balloon expandable stent systems.

Corpus specializes in the design and development of technically complex catheter technologies, with particular expertise in the fields of electrophysiology, structural heart, neurovascular, cardiovascular, peripheral vascular and ENT.

The combined company will continue to operate as Confluent Medical Technologies, and will offer complementary, industry-leading technologies to provide customers with a single-source solution for highly innovative, cost-competitive medical device contract manufacturing, testing, and design services. Confluent Medical has a proven track record of partnering with the medical device community to deliver world-class medical devices through innovative materials science, engineering, and manufacturing.

“The acquisition of Corpus Medical expands Confluent Medical’s design and manufacturing capabilities into technically complex and advanced catheters. Corpus has extensive technical capabilities in the design and development of products in the electrophysiology, ENT, peripheral vascular, and cardiovascular markets,” said Dean Schauer, President and CEO of Confluent Medical. “We look forward to engaging our customers with our expanded suite of advanced, industry-leading technologies as well as high-quality, innovative, cost-competitive manufacturing.”

“Corpus Medical is thrilled to be joining the Confluent Medical team and combining our expertise in advanced catheter design and development with Confluent’s world-class capabilities to best serve the medical device industry,” said Brice de La Menardiere, President and CEO of Corpus.

Confluent Medical’s expanded portfolio of services includes:


  • Advanced technology in sensor, energy and catheter design and development
  • Specializing in the electrophysiology, structural heart, neurovascular, ENT, peripheral vascular, and cardiovascular markets


  • Balloon expandable stent and balloon catheter production
  • Balloon manufacturing equipment
  • High-quality and cost-competitive extrusion


  • Medical textile design, development, and contract manufacturing
  • Specializing in cardiovascular and orthopedic implants


  • Precise polymer component design and production
  • Specializing in vascular delivery systems


  • Guidewire contract manufacturing
  • Specializing in hydrophilic-coated guidewires


  • Nitinol component contract manufacturing
  • Nitinol device design and testing services
  • Nitinol material

Confluent Medical and Corpus Medical are both portfolio companies of Ampersand Capital Partners. Ampersand will continue to be a significant investor in the integrated company, Confluent Medical Technologies.


Improving lives by delivering world class medical devices through innovative materials science, engineering, and manufacturing. Confluent Medical Technologies is the largest and market leading contract manufacturer of specialized medical devices. With manufacturing facilities in Fremont, California, Laguna Niguel, California, Sunnyvale, California, Warwick, Rhode Island, and San Jose, Costa Rica, Confluent Medical Technologies has a proven 20-year track record of partnering with the medical device community and delivering high-quality medical devices and components in the aortic intervention, peripheral vascular, ENT, orthopedic/spine, structural heart, electrophysiology, and neurovascular spaces.


Corpus Medical specializes in the design, development, and manufacture of advanced technology catheters for device manufacturers in the electrophysiology, peripheral vascular and cardiovascular markets. With manufacturing facilities in Campbell, California, Corpus Medical is a trusted partner to some of the world’s largest and most innovative device makers.


Founded in 1988, Ampersand is a middle market private equity firm dedicated to growth-oriented investments in the healthcare sector. Ampersand leverages its unique blend of private equity and operating experience to build value and drive superior long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of our core healthcare sectors, including Brammer Bio, Confluent Medical, Genewiz, Genoptix, Talecris Biotherapeutics and Viracor-IBT Laboratories. Additional information about Ampersand is available at


Confluent Medical Technologies
Doug Hutchison
[email protected]


Latest News

March 8, 2024

Confluent Appoints Sandy Stojkovski and Brian Yoor to its Board of Directors

Read More ›
January 25, 2024

Confluent Announces Significant Investment in ATI Nitinol Melt Expansion

Read More ›
June 23, 2023

Confluent’s New Polymer Webshop Provides Solution to PTFE Lead Time Constraints

Read More ›

Partnering with you every step of the way

Contact Confluent Medical today and make sure your project is supported by our unmatched resources, technical expertise and proven service to meet any design, modification or manufacturing requirements.